Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Curie.Biocurie.bioCurie.Bio is a venture capital firm that funds and operationally supports drug discovery companies, helping founders turn ideas into medicines from concept-stage to clinical PoC. It invests via two funds—the Seed Fund and the Breakout Fund—typically making $5-15M preclinical investments and later-stage funding to generate clinical data, with over $1B raised. Beyond funding, Curie.Bio provides a 100+ person team of drug makers, drug hunters, and support services to identify optimal target product profiles, develop efficient R&D plans, generate PoC data, and raise additional capital.
Sources
curie.bio shapes more of what AI says about Curie.Bio than any other source, at 100% of its citations.
The market map
Biotech and Health Service Providers →Where AI ranks Curie.Bio
Excerpts where Curie.Bio appeared in the AI's answer
Curie.Bio — Operating a specialized seed-funding model explicitly built for therapeutics founders, writing substantial initial checks ($5M to $15M) to help take new concepts through preclinical milestones and development candidates.
Curie.Bio (Boston) — Operates a specialized seed fund (writing checks typically $5M - $15M) dedicated to taking therapeutics through preclinical milestones to development candidates alongside deep operational support.
